{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:15:38Z","timestamp":1761894938954},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,8,25]],"date-time":"2009-08-25T00:00:00Z","timestamp":1251158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s00296-009-1104-3","type":"journal-article","created":{"date-parts":[[2009,8,24]],"date-time":"2009-08-24T06:35:56Z","timestamp":1251095756000},"page":"1511-1514","source":"Crossref","is-referenced-by-count":8,"title":["Successful treatment with adalimumab in a patient with coexisting Beh\u00e7et\u2019s disease and ankylosing spondylitis"],"prefix":"10.1007","volume":"30","author":[{"given":"Necmettin","family":"Yildiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hakan","family":"Alkan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fusun","family":"Ardic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oya","family":"Topuz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,8,25]]},"reference":[{"key":"1104_CR1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/BF02238556","volume":"15","author":"M Tosun","year":"1995","unstructured":"Tosun M, Uslu T, Imamoglu H, Bahadir S, Erdolu S, G\u00fcler M (1995) Coexisting ankylosing spondylitis and Beh\u00e7et\u2019s disease. Clin Rheum 15:619\u2013620","journal-title":"Clin Rheum"},{"key":"1104_CR2","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s002960000052","volume":"19","author":"P Borman","year":"2000","unstructured":"Borman P, Bodur H, Ak G, Bostan EE, Bar\u00e7a N (2000) The coexistence of Beh\u00e7et\u2019s disease and ankylosing spondylitis. Rheumatol Int 19:195\u2013198","journal-title":"Rheumatol Int"},{"key":"1104_CR3","first-page":"295","volume":"62","author":"MH Kallel","year":"1995","unstructured":"Kallel MH, Bejia I, Fournie A, Fournie B (1995) Beh\u00e7et syndrome with ankylosing spondylitis. Rev Rhum Engl Ed 62:295\u2013299","journal-title":"Rev Rhum Engl Ed"},{"key":"1104_CR4","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/112067219500500309","volume":"5","author":"I Beiran","year":"1995","unstructured":"Beiran I, Scharf J, Dori D, Miller B (1995) A change in ocular involvement in a patient suffering from ankylosing spondylitis and Beh\u00e7et\u2019s disease. Eur J Ophthalmol 5:192\u2013194","journal-title":"Eur J Ophthalmol"},{"key":"1104_CR5","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/ard.47.9.780","volume":"47","author":"I Oliveri","year":"1988","unstructured":"Oliveri I, Gemignani G, Busom F, Pecori F, Camerini E, Trippi D, Pasero G (1988) Ankylosing spondylitis with predominant involvement of the cervical spine in a woman with Beh\u00e7et\u2019s syndrome. Ann Rheum Dis 47:780\u2013783","journal-title":"Ann Rheum Dis"},{"key":"1104_CR6","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/ard.2006.064279","volume":"66","author":"JA Laar van","year":"2007","unstructured":"van Laar JA, Missotten T, van Daele PL, Jamnitski A, Baarsma GS, van Hagen PM (2007) Adalimumab: a new modality for Beh\u00e7et\u2019s disease? Ann Rheum Dis 66:565\u2013566","journal-title":"Ann Rheum Dis"},{"key":"1104_CR7","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/sj.eye.6702352","volume":"21","author":"B Mushtaq","year":"2007","unstructured":"Mushtaq B, Saeed T, Situnayake RD, Murray PI (2007) Adalimumab for sight-threatening uveitis in Beh\u00e7et\u2019s disease. Eye 21:824\u2013825","journal-title":"Eye"},{"key":"1104_CR8","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/ard.2003.010975","volume":"63","author":"G Haugeberg","year":"2004","unstructured":"Haugeberg G, Velken M, Johnsen V (2004) Successful treatment of genital ulcers with infliximab in Beh\u00e7et\u2019s disease. Ann Rheum Dis 63:744\u2013745","journal-title":"Ann Rheum Dis"},{"issue":"4 Suppl 45","key":"1104_CR9","first-page":"S99","volume":"25","author":"G Almoznino","year":"2007","unstructured":"Almoznino G, Ben-Chetrit E (2007) Infliximab for the treatment of resistant oral ulcers in Beh\u00e7et\u2019s disease: a case report and review of the literature. Clin Exp Rheumatol 25(4 Suppl 45):S99\u2013S102","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 3","key":"1104_CR10","doi-asserted-by":"crossref","first-page":"iii2","DOI":"10.1136\/ard.2008.100834","volume":"67","author":"DE Furst","year":"2008","unstructured":"Furst DE, Keystone EC, Kirkman B, Fleischmann R, Mease P, Breedveld FC (2008) Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2008. Ann Rheum Dis 67(Suppl 3):iii2\u2013iii25","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1104_CR11","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1097\/01.rhu.0000249894.03016.de","volume":"12","author":"P Lin","year":"2006","unstructured":"Lin P, Liang G (2006) Beh\u00e7et disease: recommendation for clinical management of mucocutaneous lesions. J Clin Rheumatol 12(6):282\u2013286","journal-title":"J Clin Rheumatol"},{"key":"1104_CR12","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/art.1780270401","volume":"27","author":"S Linden Van der","year":"1984","unstructured":"Van der Linden S, Valkenburg HA, Cats A (1984) Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis 27:361\u2013368","journal-title":"Arthritis"},{"key":"1104_CR13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/rheumatology\/31.5.299","volume":"31","author":"The International Study Group for Beh\u00e7et\u2019s Disease","year":"1992","unstructured":"The International Study Group for Beh\u00e7et\u2019s Disease (1992) Evaluation of diagnostic criteria in Beh\u00e7et\u2019s disease\u2014towards internationally agreed criteria. Br J Rheumatol 31:299","journal-title":"Br J Rheumatol"},{"key":"1104_CR14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1136\/ard.40.6.558","volume":"40","author":"H Yazici","year":"1981","unstructured":"Yazici H, Tuzlaci M, Yurdakul S (1981) A controlled survey of sacroiliitis in Beh\u00e7et\u2019s disease. Ann Rheum Dis 40:558\u2013559","journal-title":"Ann Rheum Dis"},{"key":"1104_CR15","first-page":"281","volume-title":"Recent advances in Beh\u00e7et\u2019s disease","author":"N Dilsen","year":"1986","unstructured":"Dilsen N, Koni\u00e7e M, Aral O (1986) Why Beh\u00e7et\u2019s disease should be accepted as a seronegative arthritis. In: Lehner T, Barnes CG (eds) Recent advances in Beh\u00e7et\u2019s disease. Royal Society of Medicine Services, London, pp 281\u2013284"},{"key":"1104_CR16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00002281-199401000-00007","volume":"6","author":"JD O\u2019Duffy","year":"1994","unstructured":"O\u2019Duffy JD (1994) Beh\u00e7et\u2019s disease. Curr Opin Rheumatol 6:39\u201343","journal-title":"Curr Opin Rheumatol"},{"key":"1104_CR17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1097\/00002281-199607000-00003","volume":"8","author":"J Braun","year":"1996","unstructured":"Braun J, Sieper J (1996) The sacroiliac joint in the sponyloarthropathies. Curr Opin Rheumatol 8:275\u2013287","journal-title":"Curr Opin Rheumatol"},{"key":"1104_CR18","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/1529-0131(199804)41:4<694::AID-ART17>3.0.CO;2-#","volume":"41","author":"D McGonagle","year":"1998","unstructured":"McGonagle D, Gibbon W, O\u2019Connor P, Gren M, Pease C, Emery P (1998) Characteristic magnetic resonance imaging entheseal changes of knee synovitis in spondyloarthropathy. Arthritis Rheum 41:694\u2013700","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1104_CR19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1002\/art.1780380407","volume":"38","author":"J Braun","year":"1995","unstructured":"Braun J, Bollow M, Neure L, Seipelt E, Seyrekbasan F, Herbst H, Eggens U, Distler A, Sieper J (1995) Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis. Arthritis Rheum 38(4):499\u2013505","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1104_CR20","first-page":"128","volume":"24","author":"B Turan","year":"1997","unstructured":"Turan B, Gallati H, Erdi H, G\u00fcrler A, Michel BA, Villiger PM (1997) Systemic levels of the T cell regulatory cytokines IL-10 and IL-12 in Beh\u00e7et\u2019s disease; soluble TNFR-75 as a biological marker of disease activity. J Rheumatol 24(1):128\u2013132","journal-title":"J Rheumatol"},{"key":"1104_CR21","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/rheumatology\/kem034","volume":"46","author":"PP Sfikakis","year":"2007","unstructured":"Sfikakis PP, Markomichelakis N, Alpsoy E et al (2007) Anti-TNF therapy in the management of Beh\u00e7et\u2019s disease\u2014review and basis for recommendations. Rheumatology 46:736\u2013741","journal-title":"Rheumatology"},{"key":"1104_CR22","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/ard.61.suppl_2.ii51","volume":"61","author":"PP Sfikakis","year":"2002","unstructured":"Sfikakis PP (2002) Beh\u00e7et\u2019s disease: a new target for anti-tumour necrosis factor treatment. Ann Rheum Dis 61:51\u201353","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1104_CR23","first-page":"98","volume":"32","author":"M Melikoglu","year":"2005","unstructured":"Melikoglu M, Fresko I, Mat C, Ozyazgan Y, Gogus F, Yurdakul S, Hamuryudan V, Yaz\u0131c\u0131 H (2005) Short-term trial of etanercept in Beh\u00e7et\u2019s disease: a double blind, placebo controlled study. J Rheumatol 32(1):98\u2013105","journal-title":"J Rheumatol"},{"key":"1104_CR24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/ard.60.6.637","volume":"60","author":"PH Goossens","year":"2001","unstructured":"Goossens PH, Verburg RJ, Breedveld FC (2001) Remission of Beh\u00e7et\u2019s syndrome with tumour necrosis factor \u03b1 blocking therapy. Ann Rheum Dis 60:637","journal-title":"Ann Rheum Dis"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-1104-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-009-1104-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-1104-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,28]],"date-time":"2019-05-28T07:18:33Z","timestamp":1559027913000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-009-1104-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,8,25]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["1104"],"URL":"https:\/\/doi.org\/10.1007\/s00296-009-1104-3","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,8,25]]}}}